TUBA1A and epilepsy: Heterozygous de novo TUBA1A mutations cause an autosomal dominant “tubulinopathy”, with clinical features including brain malformations, microcephaly, neurodevelopmental delay, motor impairment, cognitive deficit, and epilepsy [1,21,22].